Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Sexual dysfunction Stories

2012-05-01 23:01:33

On April 11th, 2012, the U.S. FDA announced changes to the labels for Propecia (finasteride) and Proscar to expand the list of sexual adverse events reported to FDA as some of these events have been reported to continue after the drug is no longer being used. Propecia is a pill, manufactured by Merck, for use in males only and indicated for the treatment of male pattern hair loss. It was approved by the FDA in 1997. On April 16th, 2012, sixteen federal lawsuits that alleged persistent sexual...

2012-04-29 23:02:07

Neogenis Labs contends that nitric oxide insufficiency, not testosterone, is actually to blame for aging baby boomers' sexual issues. Nitric oxide is a naturally occurring molecule in our bodies. As we age, we lose our ability to produce it. Research reveals that this molecule controls erections in men and orgasms in women. Austin, TX (PRWEB) April 28, 2012 As men age, often their sexual performance suffers. And somewhere along the way, testosterone got pegged as the problem. Dr. Craig...

2012-04-27 10:24:09

MOUNTAIN VIEW, Calif., April 27, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S. "Patients and treating physicians continue to report significant dissatisfaction with current treatments of ED,"...

2012-04-23 22:21:33

JERSEY CITY, N.J., April 24, 2012 /PRNewswire/ -- S1 Pharmaceuticals, Inc., a developer of therapeutics for disorders of women's sexual health, announced today an executive management addition and Scientific Advisory Board appointment that strengthen and expand the Company's leadership: John F. Kaufmann, M.B.A. was appointed as the Company's Chief Financial Officer. Cindy M. Meston, Ph.D. was appointed as a member of the Company's Scientific Advisory Board of Directors. "Mr....

2012-04-11 05:44:00

(Ivanhoe Newswire)-- Dialysis is a common treatment used by more then 350,000 individuals in the United States alone. Patients on dialysis commonly experience symptoms such as pain, depression, impaired sleep, and fatigue; overall impacting their quality of life. A study recently uncovered that the majority of female kidney failure patients on dialysis may also experience sexual problems. Although there is increasing awareness of erectile dysfunction in men on hemodialysis, the...

2012-04-09 02:23:33

GREENWOOD VILLAGE, Colo., April 9, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE--News) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it submitted to the FDA a pre IND package on Zertane(TM), its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US. Michael...

2012-04-06 11:01:22

4 out of 5 female dialysis patients reported sexual dysfunction Highlights:     In the largest observational study of its kind, 84% of all women and 55% of sexually active women on hemodialysis experienced sexual problems.     Sexual dysfunction was reported more often by women who were older, were less educated, had signs of depression, had reached menopause, had diabetes, and took diuretic therapy, or 'water pills.' Other studies indicate that sexual...

2012-04-02 02:27:31

GREENWOOD VILLAGE, Colo., April 2, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), announced today that it reached agreement with the Therapeutic Goods Administration (TGA), Canberra, Australia, on a plan of drug manufacture and quality control for Zertane(TM)( )and the overall plan for the preparation of Common Technical...

2012-03-30 23:00:16

Goldlite Hypnosis Institute Recently Helped Steve Overcome Sexual Dysfunction Newport Beach, CA (PRWEB) March 30, 2012 Steve Recently Overcome Sexual Dysfunction with the Help of Goldlite Hypnosis Institute Steve had a premature ejaculation problem for a long time. Things were getting worse slowly. His wife was not happy with that. She kept on nagging him to get help. Finally couple months ago he decided to use Hypnotherapy and hoped that will help him. Although he was suspicious and had...

2012-03-22 21:06:51

First national survey of OB-GYN sex history screening practices confirms narrow focus How often does your doctor ask about your sexual life? Unfortunately, the answer may be: not often enough. Leaving the subject off the check-up checklist could mean missing an important link to overall wellness. Results of a comprehensive national survey of U.S. obstetrician-gynecologists regarding communication with patients about sex have found that too often doctors aren't having "the talk" with...